$FOLD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMICUS THERAPEUTICS, INC.. Get notifications about new insider transactions in AMICUS THERAPEUTICS, INC. for free.
Page: < prev 1 ... 5 6 7 8 9 10 11 12 13 ... 28 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 21 2014 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | M | 3.32 | 5,000 | 16,600 | 0 | |
Aug 21 2014 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Sell | S | 5.40 | 12,810 | 69,174 | 50,000 | 62.8 K to 50 K (-20.39 %) |
Aug 21 2014 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Buy | P | 5.40 | 7,810 | 42,174 | 62,810 | 55 K to 62.8 K (+14.20 %) |
Aug 21 2014 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Buy | P | 5.40 | 5,000 | 27,000 | 55,000 | 50 K to 55 K (+10.00 %) |
Aug 21 2014 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 2.81 | 18,750 | 52,688 | 1,250 | |
Aug 21 2014 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 5.40 | 18,750 | 101,250 | 200,000 | 218.8 K to 200 K (-8.57 %) |
Aug 21 2014 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | P | 5.40 | 18,750 | 101,250 | 218,750 | 200 K to 218.8 K (+9.38 %) |
Jul 08 2014 | FOLD | AMICUS THERAPEUTIC ... | Doshi Dipal | SVP Business Planni ... | Option Exercise | A | 3.90 | 125,000 | 487,500 | 125,000 | |
Jul 08 2014 | FOLD | AMICUS THERAPEUTIC ... | Doshi Dipal | SVP Business Planni ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Jul 01 2014 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 3.50 | 530,000 | 1,855,000 | 12,339,444 | 11.8 M to 12.3 M (+4.49 %) |
Jul 01 2014 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 3.50 | 3,470,000 | 12,145,000 | 11,809,444 | 8.3 M to 11.8 M (+41.61 %) |
Jun 30 2014 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 2.94 | 90,000 | 264,600 | 90,000 | |
Jun 30 2014 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 100,000 | 0 | 200,000 | 100 K to 200 K (+100.00 %) |
Jun 30 2014 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | A | 2.94 | 45,000 | 132,300 | 45,000 | |
Jun 30 2014 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Option Exercise | A | 2.94 | 45,000 | 132,300 | 45,000 | |
Jun 30 2014 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | A | 2.94 | 50,000 | 147,000 | 50,000 | |
Jun 30 2014 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Option Exercise | A | 2.94 | 45,000 | 132,300 | 45,000 | |
Jun 30 2014 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Option Exercise | A | 2.94 | 45,000 | 132,300 | 45,000 | |
Jun 30 2014 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | A | 2.94 | 90,000 | 264,600 | 90,000 | |
Jun 30 2014 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | A | 2.94 | 45,000 | 132,300 | 45,000 | |
Jun 30 2014 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Option Exercise | A | 2.94 | 45,000 | 132,300 | 45,000 | |
Jun 30 2014 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | A | 2.94 | 45,000 | 132,300 | 45,000 | |
Jun 30 2014 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Option Exercise | A | 2.94 | 45,000 | 132,300 | 45,000 | |
Jun 30 2014 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | Vice President Clin ... | Option Exercise | A | 2.94 | 45,000 | 132,300 | 45,000 | |
Jun 30 2014 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 0.64 | 16,491 | 10,513 | 0 | |
Jun 30 2014 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 0.64 | 16,491 | 10,513 | 109,083 | 92.6 K to 109.1 K (+17.81 %) |
Jun 30 2014 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 3.82 | 230,000 | 878,600 | 230,000 | |
Jun 17 2014 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 2.69 | 25,000 | 67,328 | 92,592 | 67.6 K to 92.6 K (+36.99 %) |
Jun 16 2014 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Option Exercise | A | 2.80 | 15,000 | 42,000 | 15,000 | |
Jun 16 2014 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | A | 2.80 | 15,000 | 42,000 | 15,000 | |
Jun 16 2014 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | A | 2.80 | 15,000 | 42,000 | 15,000 | |
Jun 16 2014 | FOLD | AMICUS THERAPEUTIC ... | ESSNER ROBERT | Director | Option Exercise | A | 2.80 | 15,000 | 42,000 | 15,000 | |
Jun 16 2014 | FOLD | AMICUS THERAPEUTIC ... | LOVE TED W | Director | Option Exercise | A | 2.80 | 15,000 | 42,000 | 15,000 | |
Jun 16 2014 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | A | 2.80 | 15,000 | 42,000 | 15,000 | |
Jun 16 2014 | FOLD | AMICUS THERAPEUTIC ... | BARER SOL J | Director | Option Exercise | A | 2.80 | 15,000 | 42,000 | 15,000 | |
Jun 16 2014 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 2.80 | 15,000 | 42,000 | 15,000 | |
Jun 16 2014 | FOLD | AMICUS THERAPEUTIC ... | BARRETT M JAMES | Director | Option Exercise | A | 2.80 | 15,000 | 42,000 | 15,000 | |
May 12 2014 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 2.22 | 14,100 | 31,302 | 67,592 | 53.5 K to 67.6 K (+26.36 %) |
May 12 2014 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 2.21 | 900 | 1,989 | 53,492 | 52.6 K to 53.5 K (+1.71 %) |
Apr 11 2014 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | Vice President Clin ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Apr 11 2014 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Grant | A | 0.00 | 50,000 | 0 | 51,708 | 1.7 K to 51.7 K (+2,927.40 %) |
Apr 11 2014 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Apr 11 2014 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Intellectual Pr ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Apr 11 2014 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Apr 11 2014 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Apr 11 2014 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Apr 11 2014 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Apr 11 2014 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Apr 11 2014 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Business Offi ... | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Apr 11 2014 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Mar 14 2014 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 2.29 | 10,000 | 22,900 | 52,592 | 42.6 K to 52.6 K (+23.48 %) |
Mar 14 2014 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 2.26 | 22,065 | 49,867 | 994,604 | 1 M to 994.6 K (-2.17 %) |
Mar 14 2014 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 2.21 | 85,032 | 187,921 | 1,016,669 | 1.1 M to 1 M (-7.72 %) |
Mar 12 2014 | FOLD | AMICUS THERAPEUTIC ... | LOVE TED W | Director | Grant | A | 2.21 | 110,000 | 243,100 | 110,000 | 0 to 110 K |
Mar 12 2014 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 2.16 | 10,000 | 21,599 | 42,592 | 32.6 K to 42.6 K (+30.68 %) |
Mar 11 2014 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 2.21 | 17,108 | 37,809 | 32,592 | 15.5 K to 32.6 K (+110.49 %) |
Mar 11 2014 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 2.22 | 121,642 | 270,045 | 1,101,701 | 1.2 M to 1.1 M (-9.94 %) |
Mar 11 2014 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 2.28 | 108,018 | 246,281 | 1,223,343 | 1.3 M to 1.2 M (-8.11 %) |
Mar 11 2014 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 2.32 | 68,418 | 158,730 | 1,331,361 | 1.4 M to 1.3 M (-4.89 %) |
Mar 10 2014 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | A | 2.29 | 175,000 | 400,750 | 175,000 | |
Jan 07 2014 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 3.19 | 214,500 | 684,255 | 214,500 | |
Jan 07 2014 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Business Offi ... | Option Exercise | A | 2.45 | 90,000 | 220,500 | 90,000 | |
Jan 07 2014 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | Vice President Clin ... | Option Exercise | A | 2.45 | 45,000 | 110,250 | 45,000 | |
Jan 07 2014 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Option Exercise | A | 2.45 | 45,000 | 110,250 | 45,000 | |
Jan 07 2014 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Option Exercise | A | 2.45 | 45,000 | 110,250 | 45,000 | |
Jan 07 2014 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | A | 2.45 | 45,000 | 110,250 | 45,000 | |
Jan 07 2014 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Option Exercise | A | 2.45 | 45,000 | 110,250 | 45,000 | |
Jan 07 2014 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Option Exercise | A | 2.45 | 45,000 | 110,250 | 45,000 | |
Jan 07 2014 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Intellectual Pr ... | Option Exercise | A | 2.45 | 50,000 | 122,500 | 50,000 | |
Jan 07 2014 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | A | 2.45 | 90,000 | 220,500 | 90,000 | |
Jan 07 2014 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | A | 2.45 | 55,000 | 134,750 | 55,000 | |
Dec 16 2013 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 2.05 | 10,000 | 20,500 | 133,409 | 123.4 K to 133.4 K (+8.10 %) |
Nov 25 2013 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 2.08 | 10,000 | 20,800 | 123,409 | 113.4 K to 123.4 K (+8.82 %) |
Nov 22 2013 | FOLD | AMICUS THERAPEUTIC ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 2.00 | 1,500,000 | 3,000,000 | 11,315,825 | 9.8 M to 11.3 M (+15.28 %) |
Jun 20 2013 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Corporate Controlle ... | Option Exercise | A | 2.52 | 16,250 | 40,950 | 16,250 | |
Jun 20 2013 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Option Exercise | A | 2.52 | 35,000 | 88,200 | 35,000 | |
Jun 20 2013 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Option Exercise | A | 2.52 | 35,000 | 88,200 | 35,000 | |
Jun 20 2013 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Option Exercise | A | 2.52 | 35,000 | 88,200 | 35,000 | |
Jun 20 2013 | FOLD | AMICUS THERAPEUTIC ... | Macaluso Peter M | VP & Corporate Coun ... | Option Exercise | A | 2.52 | 35,000 | 88,200 | 35,000 | |
Jun 20 2013 | FOLD | AMICUS THERAPEUTIC ... | Winterbottom Joan | SVP, Human Resource ... | Option Exercise | A | 2.52 | 40,000 | 100,800 | 40,000 | |
Jun 20 2013 | FOLD | AMICUS THERAPEUTIC ... | Lockhart David J | Chief Scientific Of ... | Option Exercise | A | 2.52 | 100,000 | 252,000 | 100,000 | |
Jun 20 2013 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | A | 2.52 | 76,500 | 192,780 | 76,500 | |
Jun 20 2013 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Business Offi ... | Option Exercise | A | 2.52 | 85,000 | 214,200 | 85,000 | |
Jun 20 2013 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 2.52 | 165,000 | 415,800 | 165,000 | |
Jun 20 2013 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Intellectual Pr ... | Option Exercise | A | 2.52 | 35,000 | 88,200 | 35,000 | |
Jun 20 2013 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | A | 2.52 | 35,000 | 88,200 | 35,000 | |
Jun 20 2013 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | A | 2.52 | 35,000 | 88,200 | 35,000 | |
Jun 17 2013 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Option Exercise | A | 3.32 | 15,000 | 49,800 | 15,000 | |
Jun 17 2013 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | A | 3.32 | 15,000 | 49,800 | 15,000 | |
Jun 17 2013 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | A | 3.32 | 15,000 | 49,800 | 15,000 | |
Jun 17 2013 | FOLD | AMICUS THERAPEUTIC ... | ESSNER ROBERT | Director | Option Exercise | A | 3.32 | 15,000 | 49,800 | 15,000 | |
Jun 17 2013 | FOLD | AMICUS THERAPEUTIC ... | BARER SOL J | Director | Option Exercise | A | 3.32 | 15,000 | 49,800 | 15,000 | |
Jun 17 2013 | FOLD | AMICUS THERAPEUTIC ... | LOVE TED W | Director | Option Exercise | A | 3.32 | 15,000 | 49,800 | 15,000 | |
Jun 17 2013 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | A | 3.32 | 15,000 | 49,800 | 15,000 | |
Jun 17 2013 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 3.32 | 15,000 | 49,800 | 15,000 | |
Jun 17 2013 | FOLD | AMICUS THERAPEUTIC ... | BARRETT M JAMES | Director | Option Exercise | A | 3.32 | 15,000 | 49,800 | 15,000 | |
Mar 18 2013 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 3.49 | 18,506 | 64,586 | 113,409 | 94.9 K to 113.4 K (+19.50 %) |
Mar 18 2013 | FOLD | AMICUS THERAPEUTIC ... | BARER SOL J | Director | Buy | P | 3.40 | 25,000 | 85,000 | 45,000 | 20 K to 45 K (+125.00 %) |
Jan 30 2013 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Option Exercise | A | 3.53 | 35,000 | 123,550 | 35,000 | |
Jan 30 2013 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | A | 3.53 | 35,000 | 123,550 | 35,000 | |
Jan 30 2013 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | A | 3.53 | 35,000 | 123,550 | 35,000 | |
Jan 30 2013 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Intellectual Pr ... | Option Exercise | A | 3.53 | 35,000 | 123,550 | 35,000 | |
Jan 30 2013 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 3.53 | 165,000 | 582,450 | 165,000 | |
Jan 30 2013 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Business Offi ... | Option Exercise | A | 3.53 | 85,000 | 300,050 | 85,000 | |
Jan 30 2013 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | A | 3.53 | 76,500 | 270,045 | 76,500 | |
Jan 30 2013 | FOLD | AMICUS THERAPEUTIC ... | Lockhart David J | Chief Scientific Of ... | Option Exercise | A | 3.53 | 100,000 | 353,000 | 100,000 | |
Jan 30 2013 | FOLD | AMICUS THERAPEUTIC ... | Winterbottom Joan | SVP, Human Resource ... | Option Exercise | A | 3.53 | 33,500 | 118,255 | 33,500 | |
Jan 30 2013 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Corporate Controlle ... | Option Exercise | A | 4.38 | 8,750 | 38,325 | 8,750 | |
Jan 30 2013 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Corporate Controlle ... | Option Exercise | A | 3.53 | 8,750 | 30,888 | 8,750 | |
Nov 14 2012 | FOLD | AMICUS THERAPEUTIC ... | Winterbottom Joan | SVP, Human Resource ... | Buy | P | 4.54 | 1,665 | 7,559 | 1,665 | 0 to 1.7 K |
Aug 30 2012 | FOLD | AMICUS THERAPEUTIC ... | Winterbottom Joan | SVP, Human Resource ... | Option Exercise | A | 5.01 | 125,000 | 626,250 | 125,000 | |
Jul 17 2012 | FOLD | AMICUS THERAPEUTIC ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 6.30 | 2,949,581 | 18,582,360 | 9,815,825 | 6.9 M to 9.8 M (+42.96 %) |
Jul 11 2012 | FOLD | AMICUS THERAPEUTIC ... | ESSNER ROBERT | Director | Option Exercise | A | 6.14 | 30,000 | 184,200 | 30,000 | |
Jun 15 2012 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Option Exercise | A | 4.79 | 15,000 | 71,850 | 15,000 | |
Jun 15 2012 | FOLD | AMICUS THERAPEUTIC ... | BARER SOL J | Director | Option Exercise | A | 4.79 | 15,000 | 71,850 | 15,000 | |
Jun 15 2012 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 4.79 | 15,000 | 71,850 | 15,000 | |
Jun 15 2012 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | A | 4.79 | 15,000 | 71,850 | 15,000 | |
Jun 15 2012 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | A | 4.79 | 15,000 | 71,850 | 15,000 | |
Jun 15 2012 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | A | 4.79 | 15,000 | 71,850 | 15,000 | |
Jun 15 2012 | FOLD | AMICUS THERAPEUTIC ... | BARRETT M JAMES | Director | Option Exercise | A | 4.79 | 15,000 | 71,850 | 15,000 | |
Jun 15 2012 | FOLD | AMICUS THERAPEUTIC ... | LOVE TED W | Director | Option Exercise | A | 4.79 | 30,000 | 143,700 | 30,000 | |
Jun 06 2012 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 4.38 | 150,000 | 657,000 | 150,000 | |
Jun 06 2012 | FOLD | AMICUS THERAPEUTIC ... | Lockhart David J | Chief Scientific Of ... | Option Exercise | A | 4.38 | 80,000 | 350,400 | 80,000 | |
Jun 06 2012 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | A | 4.38 | 35,000 | 153,300 | 35,000 | |
Jun 06 2012 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Option Exercise | A | 4.38 | 35,000 | 153,300 | 35,000 | |
Jun 06 2012 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | A | 4.38 | 35,000 | 153,300 | 35,000 | |
Jun 06 2012 | FOLD | AMICUS THERAPEUTIC ... | Winkler Robert E | VP, Clin Research & ... | Option Exercise | A | 4.38 | 35,000 | 153,300 | 35,000 | |
Jun 06 2012 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Intellectual Pr ... | Option Exercise | A | 4.38 | 35,000 | 153,300 | 35,000 | |
Jun 06 2012 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | A | 4.38 | 50,000 | 219,000 | 50,000 | |
Jun 06 2012 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Business Offi ... | Option Exercise | A | 4.38 | 80,000 | 350,400 | 80,000 | |
Jun 06 2012 | FOLD | AMICUS THERAPEUTIC ... | Boudes Pol F | Chief Medical Offic ... | Option Exercise | A | 4.38 | 80,000 | 350,400 | 80,000 | |
Apr 19 2012 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | A | 4.66 | 175,000 | 815,500 | 175,000 | |
Apr 03 2012 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 0.64 | 49,931 | 31,956 | 0 | |
Apr 03 2012 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 0.64 | 49,931 | 31,956 | 59,798 | 9.9 K to 59.8 K (+506.04 %) |
Mar 13 2012 | FOLD | AMICUS THERAPEUTIC ... | Gilmore Geoffrey | SVP & General Couns ... | Option Exercise | A | 5.75 | 10,000 | 57,500 | 10,000 | |
Mar 09 2012 | FOLD | AMICUS THERAPEUTIC ... | NEW ENTERPRISE ASSOCIATES 11 L ... | 10% Owner | Buy | P | 5.70 | 925,154 | 5,273,378 | 4,584,311 | 3.7 M to 4.6 M (+25.28 %) |
Mar 09 2012 | FOLD | AMICUS THERAPEUTIC ... | BARRIS PETER J | 10% Owner | Buy | P | 5.70 | 925,154 | 5,273,378 | 4,584,311 | 3.7 M to 4.6 M (+25.28 %) |
Mar 09 2012 | FOLD | AMICUS THERAPEUTIC ... | BARRIS PETER J | 10% Owner | Buy | P | 5.70 | 214,846 | 1,224,622 | 1,066,029 | 851.2 K to 1.1 M (+25.24 %) |
Mar 09 2012 | FOLD | AMICUS THERAPEUTIC ... | KRAMLICH C RICHARD | 10% Owner | Buy | P | 5.70 | 925,154 | 5,273,378 | 4,584,311 | 3.7 M to 4.6 M (+25.28 %) |
Mar 09 2012 | FOLD | AMICUS THERAPEUTIC ... | KRAMLICH C RICHARD | 10% Owner | Buy | P | 5.70 | 214,846 | 1,224,622 | 1,066,029 | 851.2 K to 1.1 M (+25.24 %) |
Mar 09 2012 | FOLD | AMICUS THERAPEUTIC ... | NEWHALL CHARLES W III | 10% Owner | Buy | P | 5.70 | 925,154 | 5,273,378 | 4,584,311 | 3.7 M to 4.6 M (+25.28 %) |
Mar 09 2012 | FOLD | AMICUS THERAPEUTIC ... | NEWHALL CHARLES W III | 10% Owner | Buy | P | 5.70 | 214,846 | 1,224,622 | 1,066,029 | 851.2 K to 1.1 M (+25.24 %) |
Mar 09 2012 | FOLD | AMICUS THERAPEUTIC ... | PERRY MARK W | 10% Owner | Buy | P | 5.70 | 925,154 | 5,273,378 | 4,584,311 | 3.7 M to 4.6 M (+25.28 %) |
Mar 09 2012 | FOLD | AMICUS THERAPEUTIC ... | PERRY MARK W | 10% Owner | Buy | P | 5.70 | 214,846 | 1,224,622 | 1,066,029 | 851.2 K to 1.1 M (+25.24 %) |
Mar 09 2012 | FOLD | AMICUS THERAPEUTIC ... | BARRETT M JAMES | Director | Buy | P | 5.70 | 925,154 | 5,273,378 | 4,584,311 | 3.7 M to 4.6 M (+25.28 %) |
Feb 17 2012 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 6.45 | 150,000 | 967,500 | 150,000 | |
Feb 17 2012 | FOLD | AMICUS THERAPEUTIC ... | Lockhart David J | Chief Scientific Of ... | Option Exercise | A | 6.45 | 80,000 | 516,000 | 80,000 | |
Feb 17 2012 | FOLD | AMICUS THERAPEUTIC ... | Boudes Pol F | Chief Medical Offic ... | Option Exercise | A | 6.45 | 60,000 | 387,000 | 60,000 | |
Feb 17 2012 | FOLD | AMICUS THERAPEUTIC ... | Gilmore Geoffrey | SVP & General Couns ... | Option Exercise | A | 6.45 | 50,000 | 322,500 | 50,000 | |
Feb 17 2012 | FOLD | AMICUS THERAPEUTIC ... | Schaeffer Orlov S Nicole | SVP, HR & Leadershi ... | Option Exercise | A | 6.45 | 45,000 | 290,250 | 45,000 |